← Back to Screener
SeaStar Medical Holding Corporation Common Stock (ICU)
Price$2.94
Value ScoreC
Growth ScoreA
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-15.18%
Price vs S&P 500 (4W)-34.51%
VGM Score61.47
Market Capitalization$11.75M
All Metrics
Book Value / Share (Quarterly)$1.83
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-3.43
Price vs S&P 500 (YTD)14.34%
Gross Margin (TTM)93.11%
Net Profit Margin (TTM)-828.62%
EPS (TTM)$-4.78
10-Day Avg Trading Volume0.09M
EPS Excl Extra (TTM)$-4.78
EPS (Annual)$-5.86
ROI (Annual)-111.05%
Gross Margin (Annual)95.71%
Cash / Share (Quarterly)$2.34
Revenue Growth QoQ (YoY)68.94%
ROA (Last FY)-85.82%
EBITD / Share (TTM)$-4.22
Operating Margin (TTM)-832.45%
Cash Flow / Share (Annual)$-3.54
P/B Ratio1.61x
P/B Ratio (Quarterly)2.03x
Net Income / Employee (Annual)$-714,700
EV / Revenue (TTM)1.90x
Net Interest Coverage (TTM)-28.56x
ROA (TTM)-96.48%
EPS Incl Extra (Annual)$-5.86
Current Ratio (Annual)3.63x
Quick Ratio (Quarterly)2.41x
3-Month Avg Trading Volume0.12M
52-Week Price Return-75.34%
Revenue / Employee (TTM)$84,500
Tangible BV / Share (Quarterly)$-0.86
P/S Ratio (Annual)9.52x
Asset Turnover (Annual)0.09x
52-Week High$13.00
EPS Excl Extra (Annual)$-5.86
26-Week Price Return-7.26%
Quick Ratio (Annual)3.26x
13-Week Price Return13.95%
Total Debt / Equity (Annual)0.05x
Current Ratio (Quarterly)2.73x
Enterprise Value$2.73M
Asset Turnover (TTM)0.12x
Revenue / Employee (Annual)$72,600
Pretax Margin (Annual)-984.36%
Cash / Share (Annual)$3.12
3-Month Return Std Dev119.41%
Net Income / Employee (TTM)$-699,900
ROE (Last FY)-116.65%
Net Interest Coverage (Annual)-23.18x
EPS Basic Excl Extra (Annual)$-5.86
Receivables Turnover (TTM)9.94x
Total Debt / Equity (Quarterly)0.05x
EPS Incl Extra (TTM)$-4.78
ROI (TTM)-142.54%
P/S Ratio (TTM)8.18x
Revenue / Share (Annual)$0.60
Tangible BV / Share (Annual)$-0.65
Price vs S&P 500 (52W)-99.70%
Year-to-Date Return22.50%
5-Day Price Return-19.23%
EPS Normalized (Annual)$-5.86
ROA (5Y Avg)-522.93%
Net Profit Margin (Annual)-984.60%
Month-to-Date Return-20.75%
EBITD / Share (Annual)$-5.87
Operating Margin (Annual)-986.63%
LT Debt / Equity (Annual)0.03x
EPS Basic Excl Extra (TTM)$-4.78
P/B Ratio (Annual)0.83x
Inventory Turnover (TTM)1.96x
Pretax Margin (TTM)-828.41%
Book Value / Share (Annual)$2.71
Price vs S&P 500 (13W)5.70%
Beta-0.97x
Revenue / Share (TTM)$0.37
ROE (TTM)-146.29%
52-Week Low$2.07
vGradeC
gGradeA
mGradeC
vgmGradeB
Show chart for
Earnings Surprise History
Q1 26-0.90est. -0.83
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.00
4.00
4.00
4.00
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ICUSeaStar Medical Holding Corporation Common Stock | C | A | C | $2.94 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
SeaStar Medical develops extracorporeal therapies designed to reduce hyperinflammation and its damaging effects on vital organs. The company's proprietary platform targets the inflammatory cells and cytokines that drive systemic immune responses and tissue damage. It operates a single Device segment focused on commercializing these therapeutic solutions.